Ascentage Pharma

Ascentage Pharma

Ascentage Pharma

Ascentage Pharma is a globally-focused, clinical-stage biopharmaceutical company.
Founded
2009
Raised
$154.4M
Follow us
Alexa global traffic share
Latest funding
$150,000,000
Venture capital (Series C) - 2018
CCB International ArrowMark Partners YuanMing Prudence Fund +4
JPY ¥500,000,000
Venture capital (Series B) - 2016
Oriza Holdings State Development & Investment Corporation (SDIC) Yuming Capital +1
Team Size
1–10
Employees
Location
Headquarters
AVCJ

China’s Ascentage Pharma files for HK IPO

ChinaMoneyNetwork

Oriza-backed Chinese Biotechnology Firm Ascentage Pharma Files For Hong Kong IPO

$150,000,000 Venture capital (Series C)
PE HUB , AVCJ , FinSMEs

Ascentage Pharma takes in about $150 mln

Data leaks Messaging
JPY ¥500,000,000 Venture capital (Series B)
ChinaMoneyNetwork

SDIC Fund Leads $72M Series B Round In Ascentage Pharma